FDA Adverse Event Injury Summary report: N

AMPLATZER SEPTAL OCCLUDER

MDR report key: 2973527 · Received February 22, 2013

Report

Report Number
2135147-2013-00016
Event Type
Injury
Date Received
February 22, 2013
Date of Event
February 1, 2013
Report Date
February 4, 2013
Manufacturer
AGA MEDICAL CORPORATION
Product Code
MLV
PMA / PMN Number
P000039
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DURING MANUFACTURING, THIS DEVICE UNDERWENT A SERIES OF INSPECTIONS AND TESTS TO CONFIRM PROPER FUNCTION, INCLUDING A TEST SIMULATING LOADING AND DEPLOYMENT. A REVIEW OF MANUFACTURING DOCUMENTATION CONFIRMED THIS DEVICE SUCCESSFULLY COMPLETED THESE TESTS. NO PRODUCT WAS RETURNED. REVIEW OF THE DEVICE HISTORY RECORD CONFIRMED THIS LOT MET MANUFACTURING REQUIREMENTS PRIOR TO SHIPMENT. THE CAUSE FOR THE REPORTED EVENT REMAINS UNKNOWN.

Description of Event or Problem · 1

A 12MM AMPLATZER SEPTAL OCCLUDER (ASO) WAS IMPLANTED IN THE PATIENT'S VENTRICULAR SEPTAL DEFECT (VSD). SIMULTANEOUSLY, ANOTHER VSD WAS OBSERVED SO A 12MM AMPLATZER MUSCULAR VSD (MUSCVSD) WAS ATTEMPTED IN THE SECOND DEFECT BUT PULLED THROUGH THE DEFECT. THE MUSCVSD WAS REMOVED AND UPSIZED TO A 14MM ASO, HOWEVER, IT ALSO SLIPPED THROUGH THE DEFECT AND WAS REMOVED. THE PATIENT WAS REFERRED FOR SURGERY TO HAVE THE VENTRICULAR SEPTAL DEFECT REPAIRED WITH A PATCH. DURING THE SAME PROCEDURE, THE 12MM ASO WAS EXPLANTED AS ITS FORM WAS NOT APPROPRIATE FOR THE DEFECT SHAPE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
78563 AMPLATZER SEPTAL OCCLUDER CARDIAC OCCLUSION DEVICE MLV AGA MEDICAL CORPORATION 9-ASD-012 1202087396

Patients

Seq Age Sex Outcome Treatment
1 18 YR Required Intervention